Abstract
AbstractHelicobacter pylori (H. pylori) is a universal health intimidation as mentioned by the World Health Organization. The primary causal agent linked to a number of illnesses, including inflammation and the development of stomach ulcers, is Helicobacter pylori. Since, H. pylori develops antibiotic resistance quickly, current H. pylori treatment approaches are becoming less effective. Our research aims to highlight novel formulation antibiotics using CuO-NPs as catalysts and studied their activity as anti-helicobacter pylori supported by computational studies (POM analysis and molecular docking) software. They were designed for anti-Helicobacter Pylori action. All compounds revealed a bactericidal effect better than the reference McFarland standards.
Funder
Open access funding provided by Te Science, Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB).
Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB)., STDF
Zagazig University
Publisher
Springer Science and Business Media LLC